Concepedia

H. Narjes

HN

Statistics

Publications

15

Citations

1.5K

H-Index

13

Active since

1981

Affiliations

Boehringer Ingelheim (Germany)(Current)

University of Applied Sciences Biberach

Pharmazeutische Fabrik Dr. Reckeweg (Germany)

H. Narjes is an author at Boehringer Ingelheim (Germany) specializing in pharmacology, clinical pharmacology, and pharmacokinetics.

Publications per year

1981–2011

15

Publications

15

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

Daniel Lamarre, Paul C. Anderson, Murray D. Bailey et al. · Nature · 2003 · 913 citations

, , +15

Afatinib pharmacokinetics and metabolism after oral administration to healthy male volunteers

Peter Stopfer, Kristell Marzin, H. Narjes et al. · Cancer Chemotherapy and Pharmacology · 2011 · 134 citations

, , +7

Profound and Sustained Inhibition of Platelet Aggregation by Fradafiban, a Nonpeptide Platelet Glycoprotein IIb/IIIa Antagonist, and Its Orally Active Prodrug, Lefradafiban, in Men

Thomas Müller, H Weisenberger, R Brickl et al. · Circulation · 1997 · 79 citations

, , +17

Clinical pharmacokinetics of meloxicam.

Dominique Turck, Ulrich Busch, G. Heinzel et al. · PubMed · 1997 · 77 citations

, , +13

Effect of Food on the Pharmacokinetics of Meloxicam after Oral Administration

Dominique Turck, Ulrich Busch, G. Heinzel et al. · Clinical Drug Investigation · 1995 · 42 citations

, , +11

1–5 of 15